Cargando…
Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis
BACKGROUND: Vaccinating infants with a first dose of measles-containing vaccine (MCV1) before 9 months of age in high-risk settings has the potential to reduce measles-related morbidity and mortality. However, there is concern that early vaccination might blunt the immune response to subsequent meas...
Autores principales: | Nic Lochlainn, Laura M, de Gier, Brechje, van der Maas, Nicoline, van Binnendijk, Rob, Strebel, Peter M, Goodman, Tracey, de Melker, Hester E, Moss, William J, Hahné, Susan J M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science ;, The Lancet Pub. Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838663/ https://www.ncbi.nlm.nih.gov/pubmed/31548081 http://dx.doi.org/10.1016/S1473-3099(19)30396-2 |
Ejemplares similares
-
Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis
por: Nic Lochlainn, Laura M, et al.
Publicado: (2019) -
Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6–14 Months During a Measles Outbreak in The Netherlands in 2013–2014
por: van der Maas, Nicoline A. T., et al.
Publicado: (2016) -
Additional Evidence on Serological Correlates of Protection against Measles: An Observational Cohort Study among Once Vaccinated Children Exposed to Measles
por: Woudenberg, Tom, et al.
Publicado: (2019) -
Measles Outbreak, the Netherlands, 2008
por: Hahné, Susan, et al.
Publicado: (2010) -
Economic Costs of Measles Outbreak in the Netherlands, 2013–2014
por: Suijkerbuijk, Anita W.M., et al.
Publicado: (2015)